These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 461494)

  • 1. Indobufen, a new inhibitor of platelet aggregation. Studies in guinea pigs.
    Bergamaschi M; Ceserani R; Pierucci L; Pogliani E; Spelta A
    Pharmacol Res Commun; 1979 Mar; 11(3):279-94. PubMed ID: 461494
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
    Hansen MS; Birgens HS
    Ugeskr Laeger; 1980 Jan; 142(5):303-5. PubMed ID: 6243811
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivesicular structures and effects of some aggregation inhibitors in guinea-pig platelets.
    Candia Carnevali M; Salimbeni S; Spelta A
    Haematologica; 1977 Apr; 62(2):127-35. PubMed ID: 406170
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins and precursors in platelet function.
    Smith JB; Ingerman CM; Silver MJ
    Ciba Found Symp; 1975; 35():207-24. PubMed ID: 776549
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of acetylsalicylic acid. Dipyridamole and K 3920 on the secretion of platelet factor 4.
    Akman N
    Haematologica; 1980 Aug; 65(4):546-51. PubMed ID: 6774930
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific inhibition of 40 K protein phosphorylation in platelet by a new antithrombotic agent, d-indobufen.
    Mamiya S; Hagiwara M; Ishikawa T; Hidaka H
    Thromb Res; 1989 Jun; 54(5):447-56. PubMed ID: 2505401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
    Samama M; Lecrubier C; Conard J; Hotchen M; Breton-Gorius J; Vargaftig B; Chignard M; Lagarde M; Dechavanne M
    Br J Haematol; 1981 Jun; 48(2):293-303. PubMed ID: 7195274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920).
    Pogliani E; Corvi G; Mandelli V; Fuccella LM
    Haematologica; 1981 Apr; 66(2):160-70. PubMed ID: 6115794
    [No Abstract]   [Full Text] [Related]  

  • 14. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
    Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
    Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Compound Sbt-828, a New Indole Derivative Exhibiting Antiaggregant Activity, on the Prostacyclin-Thromboxane A
    Kucheryavenko AF; Spasov AA; Tian M; Suzdalev KF
    Bull Exp Biol Med; 2017 Apr; 162(6):758-761. PubMed ID: 28429213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet thromboxane A2/prostaglandin H2 receptors in human volunteers on low doses of aspirin.
    Covatto RH; Niewiarowski S
    Biochem Pharmacol; 1990 Oct; 40(7):1559-61. PubMed ID: 2145839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella.
    Vargaftig BB; Prado-Franceschi J; Chignard M; Lefort J; Marlas G
    Eur J Pharmacol; 1980 Dec; 68(4):451-64. PubMed ID: 7009169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro platelet aggregation and its inhibition by three antithrombotic drugs between human and guinea pig.
    Huang ZS; Lee TK
    Proc Natl Sci Counc Repub China B; 1991 Feb; 15(1):8-14. PubMed ID: 1946813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.